Working Party on Biotechnology, Nanotechnology and Converging Technologies
E1445081
UNEXPLORED
The Working Party on Biotechnology, Nanotechnology and Converging Technologies is an OECD expert group that advises on policy, governance, and responsible innovation related to emerging and converging science and technology fields.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Working Party on Biotechnology, Nanotechnology and Converging Technologies canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T20694774 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Working Party on Biotechnology, Nanotechnology and Converging Technologies Context triple: [Committee for Scientific and Technological Policy, hasWorkingParty, Working Party on Biotechnology, Nanotechnology and Converging Technologies]
-
A.
Working Party on Innovation and Technology Policy
The Working Party on Innovation and Technology Policy is an OECD expert group that advises on and develops international policies to foster innovation, technological development, and related economic growth.
-
B.
Subsidiary Body for Scientific and Technological Advice
The Subsidiary Body for Scientific and Technological Advice is a permanent UNFCCC body that provides governments with scientific, technical, and methodological guidance to inform international climate change negotiations and policy decisions.
-
C.
Subsidiary Body on Scientific, Technical and Technological Advice
The Subsidiary Body on Scientific, Technical and Technological Advice is a multidisciplinary expert body under the Convention on Biological Diversity that provides scientific and technical guidance to inform the treaty’s implementation and policy decisions.
-
D.
Committee for Scientific and Technological Policy
The Committee for Scientific and Technological Policy is an OECD body that guides international cooperation and policy-making on science, technology, and innovation among member countries.
-
E.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Working Party on Biotechnology, Nanotechnology and Converging Technologies Target entity description: The Working Party on Biotechnology, Nanotechnology and Converging Technologies is an OECD expert group that advises on policy, governance, and responsible innovation related to emerging and converging science and technology fields.
-
A.
Working Party on Innovation and Technology Policy
The Working Party on Innovation and Technology Policy is an OECD expert group that advises on and develops international policies to foster innovation, technological development, and related economic growth.
-
B.
Subsidiary Body for Scientific and Technological Advice
The Subsidiary Body for Scientific and Technological Advice is a permanent UNFCCC body that provides governments with scientific, technical, and methodological guidance to inform international climate change negotiations and policy decisions.
-
C.
Subsidiary Body on Scientific, Technical and Technological Advice
The Subsidiary Body on Scientific, Technical and Technological Advice is a multidisciplinary expert body under the Convention on Biological Diversity that provides scientific and technical guidance to inform the treaty’s implementation and policy decisions.
-
D.
Committee for Scientific and Technological Policy
The Committee for Scientific and Technological Policy is an OECD body that guides international cooperation and policy-making on science, technology, and innovation among member countries.
-
E.
Committee for Advanced Therapies
The Committee for Advanced Therapies is a scientific body within the European Medicines Agency responsible for evaluating and providing expert opinions on advanced therapy medicinal products such as gene, cell, and tissue-engineered therapies.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
Committee for Scientific and Technological Policy
→
hasWorkingParty
→
Working Party on Biotechnology, Nanotechnology and Converging Technologies
ⓘ